Story
Aena Shares Fall as Nine-Month Revenue Misses Expectations

Shares of Aena SME SA (AENA) declined on Wednesday after the airport operator's nine-month revenue missed analyst expectations, raising investor concerns despite a healthy rise in net profit and robust passenger traffic.
The stock fell by as much as 1.8% to trade at €26.52 after the report was published.
Revenue Miss Overshadows Strong Traffic
Aena reported revenue of €5.28 billion for the first nine months of 2026. While this marked a 10% year-over-year increase, it fell significantly short of the analyst consensus estimate of €5.69 billion, triggering selling pressure.
In contrast, the company's net profit rose 12% year-over-year to €1.77 billion, a figure that broadly met market expectations. However, investors focused on the top-line miss, which occurred despite strong operational performance.
AdAena's Spanish airports handled 257.2 million passengers during the period, a 4.1% increase that surpassed the company's own upgraded full-year growth forecast of 3%. This disconnect between strong passenger footfall and the revenue shortfall suggests investor concern that commercial and aeronautical yields are not keeping pace with traffic growth.
Analyst Caution and Market Headwinds
The negative sentiment was compounded by pre-existing caution from analysts. Ahead of the earnings release, UBS had trimmed its price target on Aena, citing a higher capital expenditure plan that is expected to push the company's net debt materially higher through the end of the decade.
Aena's stock also faced headwinds from a broader risk-off mood in European markets. Spain’s Ibex 35 index fell roughly 1% as investors were reluctant to add risk exposure ahead of the U.S. Federal Reserve’s upcoming interest rate decision, weighing on infrastructure and transport stocks across the continent.
Read next
More on Stocks
S4 Capital Cuts 2026 Revenue Forecast as Q3 Decline Accelerates
The digital advertising firm lowered its full-year net revenue guidance after reporting a 7.3% like-for-like decline in the third quarter, citing persistent macroeconomic pressures and cautious client spending.

GSK Shares Fall as Weaker Vaccine Sales and Trimmed Outlook Overshadow Earnings Beat
GSK plc shares declined despite beating third-quarter estimates, as investors focused on a significant drop in vaccine revenue and a tempered full-year profit forecast.

Intertek Q3 Organic Growth Accelerates to 6.4%, Maintains Full-Year Outlook
The quality assurance provider reported accelerated organic revenue growth in the third quarter, driven by strong performance in its Consumer Products and Industry divisions. Despite a decline in its energy business, Intertek reaffirmed its full-year guidance for 2026.

Unilever Shares Decline as Developed Market Weakness Overshadows Sales Beat
Unilever reported third-quarter sales growth that topped analyst forecasts, but shares fell as investors focused on softer performance in developed markets and a weak Foods division.